Article ; Online: Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
2023 Volume 190, Page(s) 109812
Abstract: Introduction: Proton treatment can potentially spare patients with H&N cancer for substantial treatment-related toxicities. The current study investigated the reproducibility of a decentralised model-based selection of patients for a proton treatment ... ...
Abstract | Introduction: Proton treatment can potentially spare patients with H&N cancer for substantial treatment-related toxicities. The current study investigated the reproducibility of a decentralised model-based selection of patients for a proton treatment study when the selection plans were compared to the clinical treatment plans performed at the proton centre. Methods: Sixty-three patients were selected for proton treatment in the six Danish Head and Neck Cancer (DAHANCA) centres. The patients were selected based on normal tissue complication probability (NTCP) estimated from local photon and proton treatment plans, which showed a ΔNTCP greater than 5%-point for either grade 2 + dysphagia or grade 2 + xerostomia at six months. The selection plans were compared to the clinical treatment plans performed at the proton centre. Results: Of the 63 patients, 49 and 25 were selected based on an estimated benefit in risk of dysphagia and xerostomia, respectively. Eleven patients had a potential gain in both toxicities. The mean ΔNTCP changed from the local selection plan comparison to the clinical comparison from 6.9 to 5.3 %-points (p = 0.01) and 7.3 to 4.9 %-points (p = 0.03) for dysphagia and xerostomia, respectively. Volume differences in both CTV and OAR could add to the loss in ΔNTCP. 61 of the 63 clinical plans had a positive ΔNTCP, and 38 had a ΔNTCP of 5%-points for at least one of the two endpoints. Conclusion: A local treatment plan comparison can be used to select candidates for proton treatment. The local comparative proton plan overestimates the potential benefit of the clinical proton plan. Continuous quality assurance of the delineation procedures and planning is crucial in the subsequent randomised clinical trial setting. |
|||||
---|---|---|---|---|---|---|
MeSH term(s) | Humans ; Protons ; Organs at Risk ; Deglutition Disorders/etiology ; Reproducibility of Results ; Radiotherapy Dosage ; Proton Therapy/adverse effects ; Proton Therapy/methods ; Head and Neck Neoplasms/radiotherapy ; Head and Neck Neoplasms/etiology ; Xerostomia/etiology ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Intensity-Modulated/methods | |||||
Chemical Substances | Protons | |||||
Language | English | |||||
Publishing date | 2023-07-20 | |||||
Publishing country | Ireland | |||||
Document type | Journal Article | |||||
ZDB-ID | 605646-5 | |||||
ISSN | 1879-0887 ; 0167-8140 | |||||
ISSN (online) | 1879-0887 | |||||
ISSN | 0167-8140 | |||||
DOI | 10.1016/j.radonc.2023.109812 | |||||
Shelf mark |
|
|||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1926: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.